Dataroma Value Investing
Real Time Insider Transaction Data

Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data

Selection Criteria
Timeframe :


Minimum transaction amount: $
Symbol watch list: (max. 15)
Total Transactions Amount
Buys 0 $0
Sells 66 $8,320,822
Filing
Symbol
Security Reporting Name Relationship
Trans. Date
Purchase/Sale Shares Price $
Amount $
D/I
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 03 Mar 2025 Sale 204 242.37 49,443 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 03 Mar 2025 Sale 224 243.36 54,513 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 03 Mar 2025 Sale 151 244.41 36,906 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 03 Mar 2025 Sale 111 245.26 27,224 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 03 Mar 2025 Sale 45 246.18 11,078 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 03 Mar 2025 Sale 4 247.35 989 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 03 Mar 2025 Sale 1 248.36 248 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 03 Mar 2025 Sale 465 242.69 112,851 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 03 Mar 2025 Sale 487 243.94 118,799 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 03 Mar 2025 Sale 219 245.3 53,721 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 04 Mar 2025 Sale 121 239.24 28,948 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 04 Mar 2025 Sale 328 240.95 79,032 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 04 Mar 2025 Sale 324 241.68 78,304 D
05 Mar 2025 16:22 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 04 Mar 2025 Sale 71 242.93 17,248 D
03 Mar 2025 16:30 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 28 Feb 2025 Sale 27 236.51 6,386 D
03 Mar 2025 16:30 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 28 Feb 2025 Sale 21 238.33 5,005 D
03 Mar 2025 16:30 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 28 Feb 2025 Sale 22 239.18 5,262 D
03 Mar 2025 16:30 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 28 Feb 2025 Sale 48 240.32 11,535 D
03 Mar 2025 16:30 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 28 Feb 2025 Sale 79 241.51 19,079 D
03 Mar 2025 16:30 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 28 Feb 2025 Sale 187 242.44 45,336 D
03 Mar 2025 16:30 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 28 Feb 2025 Sale 75 243.23 18,242 D
03 Mar 2025 16:30 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 28 Feb 2025 Sale 37 244.11 9,032 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 14 Feb 2025 Sale 145 252.5 36,612 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 14 Feb 2025 Sale 164 253.37 41,553 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 14 Feb 2025 Sale 110 254.35 27,978 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 14 Feb 2025 Sale 47 255.56 12,011 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 14 Feb 2025 Sale 53 256.29 13,583 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 14 Feb 2025 Sale 26 257.51 6,695 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 14 Feb 2025 Sale 33 258.07 8,516 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 14 Feb 2025 Sale 12 259.72 3,117 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 14 Feb 2025 Sale 21 260.57 5,472 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 14 Feb 2025 Sale 26 261.45 6,798 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 14 Feb 2025 Sale 12 263.33 3,160 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 14 Feb 2025 Sale 14 264.87 3,708 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 18 Feb 2025 Sale 1,086 250.21 271,728 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 18 Feb 2025 Sale 115 251.6 28,934 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 18 Feb 2025 Sale 80 256.05 20,484 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 18 Feb 2025 Sale 76 257.79 19,592 D
18 Feb 2025 16:47 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 18 Feb 2025 Sale 83 259.1 21,505 D
27 Nov 2024 17:20 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 26 Nov 2024 Sale 26 247.77 6,442 D
27 Nov 2024 17:20 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 26 Nov 2024 Sale 215 249.6 53,664 D
27 Nov 2024 17:20 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 26 Nov 2024 Sale 318 250.68 79,716 D
27 Nov 2024 17:20 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 26 Nov 2024 Sale 826 251.42 207,673 D
27 Nov 2024 17:20 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 26 Nov 2024 Sale 84 252.27 21,191 D
27 Nov 2024 17:20 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 27 Nov 2024 Sale 210 250.45 52,594 D
27 Nov 2024 17:20 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 27 Nov 2024 Sale 851 251.98 214,435 D
27 Nov 2024 17:20 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 27 Nov 2024 Sale 360 253.44 91,238 D
27 Nov 2024 17:20 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 27 Nov 2024 Sale 110 254.48 27,993 D
14 Aug 2024 16:12 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 12 Aug 2024 Sale 135 274.65 37,078 D
14 Aug 2024 16:12 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 12 Aug 2024 Sale 1,158 273.73 316,979 D
14 Aug 2024 16:12 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 12 Aug 2024 Sale 5,736 271.32 1,556,292 D
14 Aug 2024 16:12 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 12 Aug 2024 Sale 3,913 272.43 1,066,019 D
14 Aug 2024 16:12 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 12 Aug 2024 Sale 9,662 270.17 2,610,383 D
14 Aug 2024 16:12 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 12 Aug 2024 Sale 1,421 268.66 381,766 D
26 Jun 2024 16:26 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 25 Jun 2024 Sale 125 235.19 29,399 D
26 Jun 2024 16:26 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 25 Jun 2024 Sale 138 234.66 32,383 D
26 Jun 2024 16:26 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 25 Jun 2024 Sale 86 233.53 20,084 D
26 Jun 2024 16:26 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 25 Jun 2024 Sale 161 232.54 37,439 D
26 Jun 2024 16:26 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 25 Jun 2024 Sale 74 231.59 17,138 D
26 Jun 2024 16:26 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 25 Jun 2024 Sale 227 229.93 52,194 D
26 Jun 2024 16:26 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 25 Jun 2024 Sale 198 229.06 45,354 D
26 Jun 2024 16:26 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 25 Jun 2024 Sale 96 228.3 21,917 D
26 Jun 2024 16:26 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 25 Jun 2024 Sale 26 226.82 5,897 D
26 Jun 2024 16:26 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 25 Jun 2024 Sale 13 225.55 2,932 D
26 Jun 2024 16:26 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 25 Jun 2024 Sale 9 224.17 2,018 D
26 Jun 2024 16:26 ALNY ALNYLAM PHARMACEUTICALS Inc FITZGERALD KEVIN JOSEPH CSO & EVP, Head of Research 25 Jun 2024 Sale 45 221.71 9,977 D

* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)